Disease Management for Coronary Artery Patients

This randomized controlled trial was conducted with 58 patients hospitalized in the cardiology clinic of a state hospital. Personal Information Form, Anthropometric measurements, Framingham risk score, and compliance questionnaire (CQ) were used to collect the data.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Patient Empowerment Arterial Occlusive Diseases Arteriosclerosis Behavior Cardiovascular Diseases Coronary Artery Disease Coronary Disease Health Behavior Heart Diseases Myocardial Ischemia Patient Acceptance of Health Care Patient Compliance Patient Participation Treatment Adherence and Compliance Vascular Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Kilis 7 Aralık University

Kilis, 79100, Turkey (Türkiye)

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

aged 18 and over,
diagnosed with coronary artery disease for at least 2 months,
no hearing and vision problem,
no perception and expression deficiency,
not diagnosed with any psychiatric disease,
living in Kilis province,
voluntary to participate in the study.

Exclusion criteria

aged 18 under,
diagnosed without coronary artery disease for at least 2 months,
hearing and vision problem,
perception and expression deficiency,
diagnosed with any psychiatric disease,
no living in Kilis province,
no voluntary to participate in the study.

Treatment and study plan

Patient Education

Other

The data collection process of the study was carried out in two stages using data collection tools.

First stage: Personal Information Form and Compliance Questionnaire were applied to all patients in both groups. After anthropometric measurements, Framingham Risk Score was determined. The data collection forms were filled with the patients using face-to-face interview technique. The data collection process lasted for approximately 10-15 minutes. After the data collection, the patients in the intervention group were trained. No training was given to the patients in the control group but they received a "Coronary Artery Disease Management Guide".

Second stage: 12 weeks after the first interview, the patients were interviewed again face-to-face interview technique and the forms and measurements applied initially were repeated.

Primary outcomes

Compliance Questionnaire Scores of the Participants

Time frame: Initially-12 weeks

Compliance Questionnaire is a form allowing to investigate 11 different areas such as the use of medication causing maladaptation in disease management in individuals with chronic illnesses, diet, weight loss, limiting physical activity, exercise, coping with stress, alcohol use, smoking, sexual activity problems, caffeine intake and working/job life. In the form allowing Likert-type evaluation, the participant is expected to select one of the options 0 (never), 1 (very rarely), 2 (sometimes), 3 (most of the time) or 4 (always) while expressing his/her compliance level for each adaptation area. The scores corresponding to the given expression are summed and Compliance Questionnaire score for each participant is determined. The score range that can be obtained for each subscale is 0-4. The Compliance Questionnaire total scores is between 0-44. High scores mean a better as it an increase in the compliance level to the disease.

Sponsors and collaborators

Lead sponsor

Kilis 7 Aralik University

Other

Registry information

Official study title

The Effect of Training Given to Coronary Artery Patients on Disease Management

Important dates

Study start: 2019
Primary completion: 2019
Study completion: 2020
First posted: Sep 21, 2020
Registry last updated: Aug 21, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed